Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trialMore about Open Access at the Crick
Authors listMolebogeng X Rangaka Robert Wilkinson Andrew Boulle Judith R Glynn Katherine Fielding Gilles van Cutsem Katalin Wilkinson Rene Goliath Shaheed Mathee Eric Goemaere Gary Maartens
Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more common in people with HIV than in people without HIV. We aimed to assess the effect of isoniazid preventive therapy on the risk of tuberculosis in people infected with HIV-1 concurrently receiving antiretroviral therapy.
Issue number 9944
Full text links
Publisher website (DOI) 10.1016/s0140-6736(14)60162-8
Europe PubMed Central 24835842
Type of publication